Which statement is accurate regarding the use of loratadine in infants?

The statement that safety has not been established in children under 2 is accurate because clinical studies and safety data for loratadine, an antihistamine, typically exclude younger age groups, particularly infants and toddlers. As a result, health professionals often exercise caution when considering loratadine for children below the age of 2, as the effects and safety profile in this age group are not well understood.

It is important to prioritize safety in medication administration, particularly for young children, whose physiological responses can differ significantly from those of older children and adults. Without sufficient data from clinical trials specifically involving this age demographic, recommending loratadine for infants may pose risks that are not sufficiently mitigated. This statement emphasizes the need for careful consideration and adherence to age-specific guidelines in medication use for infants and young children.